BamSEC and AlphaSense Join Forces
Learn More

TETRALOGIC PHARMACEUTICALS Corp

Formerly NASDAQ: TLOG
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 62 pages Form of Exchange and Consent Agreement
12/34/56
EX-10.3
from 8-K 10 pages Voting Agreement
12/34/56
EX-10.3
from DEFA14A 10 pages Voting Agreement
12/34/56
EX-10.2
from 8-K 31 pages TETRALOGIC PHARMACEUTICALS Corporation Debt Exchange November 2, 2016
12/34/56
EX-10.2
from DEFA14A 31 pages TETRALOGIC PHARMACEUTICALS Corporation Debt Exchange November 2, 2016
12/34/56
EX-10.1
from DEFA14A 49 pages Asset Purchase Agreement by and Among TETRALOGIC PHARMACEUTICALS Corporation, Tetralogic Research and Development Corporation and Medivir Ab Dated as of November 2, 2016 Asset Purchase Agreement
12/34/56
EX-10.1
from 8-K 49 pages Asset Purchase Agreement by and Among TETRALOGIC PHARMACEUTICALS Corporation, Tetralogic Research and Development Corporation and Medivir Ab Dated as of November 2, 2016 Asset Purchase Agreement
12/34/56
EX-10.1
from 10-Q 7 pages Consulting Agreement
12/34/56
EX-10.1
from 8-K 42 pages Purchase Agreement
12/34/56
EX-10.3
from 10-Q 2 pages First Amendment to Executive Employment Agreement
12/34/56
EX-10.2
from 10-Q 9 pages Exchange Agreement
12/34/56
EX-10.1
from 10-Q 9 pages Exchange Agreement
12/34/56
EX-10.1
from 8-K 42 pages TETRALOGIC PHARMACEUTICALS Corporation At-The-Market Equity Offering Sales Agreement
12/34/56
EX-10.1
from 8-K 18 pages Indemnification Agreement
12/34/56
EX-10.5
from 10-Q 51 pages TETRALOGIC PHARMACEUTICALS Corporation $47,000,000 Convertible Senior Notes Due 2019 Purchase Agreement June 17, 2014 Purchase Agreement
12/34/56
EX-10.3
from 10-Q 24 pages Licence Agreement the Walter & Eliza Hall Institute of Medical Research TETRALOGIC PHARMACEUTICALS Corporation
12/34/56
EX-10.2
from 10-Q 30 pages License Agreement
12/34/56
EX-10.1
from 10-Q 79 pages Merger Agreement by and Among Shape Pharmaceuticals, Inc. TETRALOGIC PHARMACEUTICALS Corporation, TLOG Acquisition Sub, Inc., and Augustine Lawlor as Holder Representative, April 7, 2014
12/34/56
EX-10.1
from 8-K 22 pages TETRALOGIC PHARMACEUTICALS Corporation Executive Employment Agreement
12/34/56
EX-10.19
from S-1/A 13 pages TETRALOGIC Pharmaceutical Corporation Amended and Restated 2013 Equity Incentive Plan
12/34/56